Literature DB >> 1496917

The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas.

T Funato1, E Yoshida, L Jiao, T Tone, M Kashani-Sabet, K J Scanlon.   

Abstract

The results presented here demonstrate that expression of a fos ribozyme limits Fos protein synthesis and enhances sensitivity of A2780DDP cells to antineoplastic agents, including cisplatin. Moreover, the reversal of this resistance is associated with down-regulation of dTMP synthase, DNA polymerase beta, topoisomerase I and hMTII-A, genes previously linked to DNA synthesis and repair. Thus these studies further implicate the role of the c-fos gene in DNA synthesis through modulation of expression of dTMP syntase, DNA polymerase beta and topoisomerase I. Finally, the use of ribozymes to circumvent drug resistance suggests their potential utility as agents to inhibit tumor cell growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496917     DOI: 10.1016/0065-2571(92)90017-t

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  13 in total

1.  Genomic imbalances associated with acquired resistance to platinum analogues.

Authors:  B Leyland-Jones; L R Kelland; K R Harrap; L R Hiorns
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 3.  A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.

Authors:  R M Post; S R Weiss
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

4.  Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells.

Authors:  Y Ohta; H Kijima; T Ohkawa; M Kashani-Sabet; K J Scanlon
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

5.  Ribozyme-mediated reversal of the multidrug-resistant phenotype.

Authors:  K J Scanlon; H Ishida; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

6.  mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.

Authors:  C Daly; S Coyle; S McBride; L O'Driscoll; N Daly; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

7.  An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.

Authors:  Z Xing; J L Whitton
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.

Authors:  J K Cui; C Y Hsu; P K Liu
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 9.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 10.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.